Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5TK5

Crystal structure of human 3HAO with iron bound in the active site

Summary for 5TK5
Entry DOI10.2210/pdb5tk5/pdb
Descriptor3-hydroxyanthranilate 3,4-dioxygenase, FE (III) ION, SULFATE ION, ... (4 entities in total)
Functional Keywords3-hydroxyanthranilate oxygenase dioxygenase, cupin kynurenine pathway, oxidoreductase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight33236.41
Authors
Pidugu, L.S.,Toth, E.A. (deposition date: 2016-10-06, release date: 2017-04-12, Last modification date: 2023-10-04)
Primary citationPidugu, L.S.,Neu, H.,Wong, T.L.,Pozharski, E.,Molloy, J.L.,Michel, S.L.,Toth, E.A.
Crystal structures of human 3-hydroxyanthranilate 3,4-dioxygenase with native and non-native metals bound in the active site.
Acta Crystallogr D Struct Biol, 73:340-348, 2017
Cited by
PubMed Abstract: 3-Hydroxyanthranilate 3,4-dioxygenase (3HAO) is an enzyme in the microglial branch of the kynurenine pathway of tryptophan degradation. 3HAO is a non-heme iron-containing, ring-cleaving extradiol dioxygenase that catalyzes the addition of both atoms of O to the kynurenine pathway metabolite 3-hydroxyanthranilic acid (3-HANA) to form quinolinic acid (QUIN). QUIN is a highly potent excitotoxin that has been implicated in a number of neurodegenerative conditions, making 3HAO a target for pharmacological downregulation. Here, the first crystal structure of human 3HAO with the native iron bound in its active site is presented, together with an additional structure with zinc (a known inhibitor of human 3HAO) bound in the active site. The metal-binding environment is examined both structurally and via inductively coupled plasma mass spectrometry (ICP-MS), X-ray fluorescence spectroscopy (XRF) and electron paramagnetic resonance spectroscopy (EPR). The studies identified Met35 as the source of potential new interactions with substrates and inhibitors, which may prove useful in future therapeutic efforts.
PubMed: 28375145
DOI: 10.1107/S2059798317002029
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.88 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon